Histidine

Histidine

SCHEMBL28801818

CC(O)C(N)C(=O)O.NC(=O)CC(N)C(=O)O.NC(Cc1c[nH]cn1)C(=O)O.O=C(O)[C@@H]1CCCN1.O=C(O)[C@@H]1CCCN1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC5A2

The experimentally established mechanism targets of Histidine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Histidine SCHEMBL27660744 0.94 CYP3A4 (0.30)
Histidine SCHEMBL1543511 0.94 CYP3A4 (0.30)
Histidine SCHEMBL5583260 0.93 CYP3A4 (0.31)
Histidine SCHEMBL28519332 0.93 MEN1 (0.31)
Histidine SCHEMBL28528367 0.91
Histidine SCHEMBL19809592 0.91
Histidine SCHEMBL27660746 0.89 SLC7A5 (0.31)
Histidine SCHEMBL16444321 0.88 CYP3A4 (0.32)
Histidine SCHEMBL2586200 0.87 SLC7A5 (0.35)
D-Histidine SCHEMBL11606906 0.87 SLC7A5 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114853848-B Polypeptide compound and application thereof in preparation of medicines for treating liver fibrosis diseases 陕西慧康生物科技有限责任公司 2023-10-24 CN disclosed
CN-114853848-A Polypeptide compound and application thereof in preparing medicament for treating hepatic fibrosis diseases 陕西慧康生物科技有限责任公司 2022-08-05 CN disclosed